Table 5. Statistical significance of serum oxidative stress markers based on clinical parameters.
| Parameters | Groups | TADA | AOPP | SOD | Gpx | MDA | Ser | TF | Vit A | Vit E |
|---|---|---|---|---|---|---|---|---|---|---|
| Gender |
Female |
** |
|
|
|
** |
|
|
|
*** |
| |
Male |
** |
|
|
|
** |
|
|
* |
*** |
| Age (years) |
<40 |
* |
|
*** |
|
* |
|
* |
|
*** |
| |
40–60 |
*** |
|
|
|
*** |
|
* |
|
*** |
| |
>60 |
|
|
|
* |
* |
|
|
|
*** |
| Visual acuity |
N |
* |
|
|
|
*** |
* |
* |
|
*** |
| |
D |
|
|
* |
|
* |
|
|
|
* |
| IOP |
N |
*** |
|
* |
|
* |
* |
|
* |
*** |
| |
U |
* |
|
|
|
*** |
|
|
|
*** |
| |
B |
|
|
* |
|
*** |
* |
|
|
*** |
| c/d |
N |
*** |
|
* |
*** |
*** |
* |
* |
|
|
| |
U |
|
|
|
|
** |
|
* |
|
** |
| |
B |
* |
|
|
*** |
* |
|
|
|
*** |
| Angle |
Wide |
*** |
|
|
* |
*** |
|
* |
|
*** |
| |
Narrow |
|
|
|
|
* |
*** |
|
* |
*** |
| Drugs |
(-) |
|
|
* |
* |
*** |
|
* |
|
*** |
| |
PG |
* |
|
|
|
* |
|
|
* |
** |
| |
β-b |
|
|
* |
|
** |
|
|
|
** |
| |
2 drugs |
|
|
|
|
|
|
|
|
|
| |
3 drugs |
|
|
|
|
|
|
|
|
|
| Px |
(+) |
|
* |
|
|
*** |
|
|
|
** |
| (-) | * | ** | * |
TADA: total antioxidant capacity, AOPP: advanced oxidation protein products, SOD: superoxide dismutase, Gpx: glutathione peroxidase, MDA: malonyl dialdehyde, Ser: Serine, TF: transferrine, Vit A: vitamin A, Vit: E: vitamin E, U: Unilateral, B: Bilateral, D: Decreased, N: Normal, PG: Prostaglandin analogous, β-b: β-blocker, n: number, *:p<0.01 moderately significant,**: p<0.005 very significant, ***: p<0.001 extremely significant.